Brief: SpectraCure Announces Preliminary Results From Prostate Cancer Study
16/06/2025 13:04
June 16 (Reuters) - SpectraCure AB (publ) SPEC.ST: ANNOUNCES PRELIMINARY RESULTS FROM PROSTATE CANCER STUDY INITIAL RESULTS SHOW DECREASED PSA LEVELS MRI SHOWS TARGETED TUMOR AREA AS PER PLAN PATIENTS TO BE FOLLOWED UP FOR 12 MONTHS TO EVALUATE LONG-TERM RESULTS Source text: ID:nMFN1hl5LL Further company coverage: SPEC.ST (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))